AOD-9604 primarily targets fat metabolism MOTS-c focuses on mitochondrial function and metabolic efficiency Tesamorelin increases physiologic growth hormone release and reduces visceral fat Semaglutide reduces appetite through GLP-1 signaling Tirzepatide combines GLP-1 and GIP receptor activation and currently delivers some of the most impressive weight-loss results seen in modern medicine Understanding these differences is essential when choosing the right therapy for weight loss, metabolic health, body composition, or long-term wellness goals
Tests like Vibrant's Total Tox Burden panel quantify toxicant load to empower clinicians to remove exposure sources and initiate targeted support
Mishra, S., Stierman, B., Gahche, J., & Potischman, N
Stress may act synergistically on enteric glial cells with other factors, such as diet and infection, in the pathogenesis of ENGs, including depression